TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Swetrade Pharmaceuticals AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
2,723
|
2,308
|
1,791 |
| Financial expenses |
0
|
43
|
0 |
| Earnings before taxes |
139
|
85
|
143 |
| EBITDA |
136
|
39
|
143 |
| Total assets |
1,975
|
1,996
|
1,712 |
| Current assets |
1,849
|
1,878
|
1,547 |
| Current liabilities |
376
|
631
|
381 |
| Equity capital |
1,001
|
806
|
743 |
| - share capital |
101
|
95
|
98 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
50.7%
|
40.4%
|
43.4% |
| Turnover per employee |
1,362
|
1,154
|
896 |
| Profit as a percentage of turnover |
5.1%
|
3.7%
|
8.0% |
| Return on assets (ROA) |
7.0%
|
6.4%
|
8.4% |
| Current ratio |
491.8%
|
297.6%
|
406.0% |
| Return on equity (ROE) |
13.9%
|
10.5%
|
19.2% |
| Change turnover |
251
|
571
|
-434 |
| Change turnover % |
10%
|
33%
|
-20% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.